Pediatric aplastic anemia is a rare condition in which a child’s bone marrow stops making enough red blood cells, white blood cells, and platelets. Most cases are acquired and caused by the child’s own immune system attacking the blood-forming stem cells, while a smaller number are inherited marrow failure syndromes such as Fanconi anemia. It is serious, but it is treatable: a bone marrow transplant from a matched sibling or immunosuppressive therapy restores blood production in many children, and supportive care keeps them safe in the meantime.
For parents, the diagnosis often arrives suddenly, after bruising or a string of infections leads to a blood test. In this guide I explain what is happening in the marrow, how the diagnosis is confirmed, how severity is graded, and what the treatment path usually looks like.
What Is Pediatric Aplastic Anemia?
The term anemia usually refers to a low hemoglobin, but aplastic anemia is broader. It is a form of bone marrow failure in which the bone marrow becomes empty of the cells that make blood. The result is pancytopenia: low counts of all three main blood cell types.
At the root of the problem are hematopoietic stem cells, the rare parent cells that continuously replenish the blood. A healthy marrow produces an enormous number of new cells every day, so when stem cells are lost, counts fall steadily. Unlike leukemia, the marrow is not crowded out by abnormal cells; it is simply hollowed out and replaced by fat.
Causes and Risk Factors
Causes fall into two broad groups, and telling them apart is one of the most important early steps because it changes treatment.
Acquired aplastic anemia
Most children have acquired disease with no obvious trigger, described as idiopathic. The best-understood mechanism is immune: T cells mistakenly attack the child’s own stem cells. This is why immunosuppressive treatment works for many patients.
Recognized triggers include:
- Viral infections, particularly a form of hepatitis not caused by the known hepatitis viruses, and less often Epstein-Barr virus
- Drugs, including chemotherapy and, rarely, certain antibiotics and anticonvulsants
- Toxins such as benzene and some pesticides
- Ionizing radiation at high doses
Inherited bone marrow failure syndromes
Inherited syndromes account for a meaningful share of childhood cases. Fanconi anemia is the best known; it impairs DNA repair and may come with short stature, thumb or forearm abnormalities, and skin pigment changes. Dyskeratosis congenita, a disorder of telomere maintenance, and Shwachman-Diamond syndrome are others. Some children with inherited syndromes look entirely normal, which is why testing is done even without physical signs.
| Feature | Acquired (immune) aplastic anemia | Inherited marrow failure |
|---|---|---|
| Usual cause | Immune attack on stem cells | Gene defect in DNA repair, telomeres, or ribosomes |
| Physical findings | Usually none | Sometimes skeletal, skin, nail, or growth changes |
| Family history | Usually negative | May be positive |
| Response to immunosuppression | Often responds | Does not respond |
| Long-term concerns | Relapse, clonal evolution | Cancer predisposition, other organ involvement |
Signs and Symptoms in Children
Symptoms reflect whichever cell line is lowest, and they often build over weeks.
- From low red cells: tiredness, pale skin, headaches, breathlessness with play, and a racing heart.
- From low white cells (neutropenia): frequent or unusually severe infections, mouth ulcers, and fevers.
- From low platelets: easy bruising, nosebleeds, bleeding gums, and petechiae, tiny red or purple dots on the skin.
Children with aplastic anemia usually do not have swollen lymph nodes, an enlarged liver or spleen, or bone pain. When those are present, doctors look harder for leukemia or another diagnosis.
Diagnosis and Severity Grading
The workup begins with a complete blood count showing pancytopenia and a low reticulocyte count, confirming the marrow is not responding. A blood smear checks for abnormal or immature cells.
Bone marrow examination
A bone marrow aspirate and trephine biopsy are essential. The aspirate lets the pathologist look at individual marrow cells, while the biopsy shows overall cellularity. In aplastic anemia the marrow is hypocellular, mostly fat with few blood-forming cells and no infiltration by abnormal cells. Chromosome studies are performed on the sample too.
Ruling out other causes
Pancytopenia in a child can also come from leukemia, myelodysplastic syndrome, and other hematologic disorders. Additional tests usually include:
- A chromosome breakage test for Fanconi anemia
- Telomere length and gene panels for other inherited syndromes
- Flow cytometry for PNH clones, small populations of cells lacking certain surface proteins
- Viral studies, liver function tests, and vitamin B12 and folate levels
How severity is graded
| Category | Criteria (standard definitions) |
|---|---|
| Severe | Marrow cellularity under 25%, plus at least two of: neutrophils under 500/µL, platelets under 20,000/µL, reticulocytes under 20,000/µL |
| Very severe | Meets severe criteria with neutrophils under 200/µL |
| Non-severe | Hypocellular marrow and low counts not meeting severe criteria |
Severity guides how urgently definitive treatment is started.
Treatment Options
Treatment is delivered by a pediatric hematology and transplant team and depends on severity, cause, and donor availability.
Bone marrow (stem cell) transplantation
For severe acquired aplastic anemia, a transplant from an HLA-matched sibling is the preferred first treatment for most children because it can cure the disease. Where no sibling match exists, well-matched unrelated donors and, in experienced centers, haploidentical (half-matched) family donors are increasingly used. Children with inherited syndromes such as Fanconi anemia need specially adapted, gentler conditioning regimens.
Immunosuppressive therapy
When transplant is not immediately possible, the standard alternative is anti-thymocyte globulin (ATG) combined with cyclosporine, which calms the immune attack so stem cells can recover. Response takes weeks to months. Eltrombopag, a drug that stimulates stem cells, may be added in some settings. Immunosuppression does not help inherited marrow failure.
Supportive care
- Red cell and platelet transfusions, using irradiated and filtered products
- Prompt antibiotics for any fever, treated as an emergency
- Antifungal and antiviral prevention in selected children
- Monitoring for iron overload after many transfusions
When to See a Doctor
Contact your child’s doctor promptly if they have unexplained bruising or petechiae, persistent paleness and fatigue, or repeated infections. For a child already diagnosed, a fever is an emergency: go straight to hospital, because infection can progress quickly when neutrophils are very low. Bleeding that will not stop, a severe headache, or unusual drowsiness also needs immediate care.
Frequently Asked Questions
Is pediatric aplastic anemia a type of cancer?
No. Aplastic anemia is marrow failure, not a cancer; the marrow is empty rather than filled with malignant cells. However, it is treated by hematology and oncology teams, and some inherited forms carry a higher long-term risk of certain cancers.
Can children fully recover from aplastic anemia?
Many do. A successful matched sibling transplant can cure the condition, and many children respond well to immunosuppressive therapy. Long-term follow-up is still needed to watch for relapse and late effects of treatment.
Is aplastic anemia inherited?
Most childhood cases are acquired, not inherited. A minority are caused by inherited syndromes such as Fanconi anemia or dyskeratosis congenita, which is why genetic testing is part of the standard workup, especially before choosing a sibling donor.
Can my child go to school during treatment?
It depends on the stage of treatment and the neutrophil count. During transplant and periods of very low counts, most children stay home to reduce infection risk. Your team will advise when returning to school and activities is safe.
